by Natalie Harper | Jun 3, 2025 | Blog, Good Distribution Practice - GDP, MHRA, WDA(H)
It is common in today’s rapidly evolving pharmaceutical sector that companies need to outsource key activities. This can be for several reasons including specialist expertise, specialist storage facilities, capacity of both facilities and people, cost to your organisation and time.
by Jackie (née Heneghan) Peck | May 23, 2025 | Blog, Good Distribution Practice - GDP, MHRA
GDP certificates are not being automatically extended to the end of 2025 if they are approaching their expiry or have already expired.
by John Finey | May 8, 2025 | Blog
Following a government consultation, updated guidance on the application and implications of Intellectual Property (IP) restrictions has been published. Essentially there is no change to the rules that were established following Brexit, but it is important for businesses who participate in this trading style are aware of the rules.
by Steven Hewison | Apr 30, 2025 | Blog, MHRA
The MHRA continue to scrutinise and take action against Pharmacies and Clinics who are promoting Prescription Only Medicines (POMs) to the public. However, this month’s advertising investigations bulletin also includes action against a journalist newspaper article.
by Natalie Harper | Apr 23, 2025 | Blog, RPi, Training, Uncategorized
The Responsible Person for Import (RPi) is an important role to maintain oversight of the supply chain of medicines imported for use in the UK.
by Steven Hewison | Apr 15, 2025 | Blog, GPhC, Pharmacist, Pharmacy
In this blog I want to highlight some critical updates from the General Pharmaceutical Council (GPhC) that every pharmacy professional—whether you’re a pharmacist, technician, or pharmacy owner—should be aware of. These issues have prompted serious regulatory concerns and demand thoughtful consideration and action where appropriate.
by Steven Hewison | Apr 9, 2025 | Blog, Pharmacy
Risk Assessments are a regulatory requirement in medicines wholesaling but have you considered that they could also be very useful in pharmacy practice?
by Steven Hewison | Apr 2, 2025 | Blog, MHRA, Pharmacy Suppliers
The MHRA have updated their Blue Guide on Advertising and Promoting Medicines. The update is to Appendix 4 with new Best Practice guidance on the sale of medicines for pain relief.
by Kimberley Peck | Mar 14, 2025 | Blog, Pharmacy
Are you advertising Prescription Only Medicines (POM) utilising a prescribing service? Do you know it is illegal to advertise a POM?
by Kimberley Peck | Mar 10, 2025 | Blog, Pharmacy
The GPhC has released new standards for the Chief Pharmacist in January 2025. Have you read them? This blog summarises the standards provided. Find them in their entirety here.